Robert F Dunn

This inventor holds 19 USPTO granted patents and 6 published patent applications and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Memory Pharmaceuticals Corporation, Memory Pharmaceutical Corporation. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert F Dunn. Retrieved from https://idiyas.com/inventor/robert-f-dunn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 6)

% Patents Active = 57.9

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 7.6

ph-index = 7

Forward Citations = 110(Granted Patents)

Company Filing History:

13 out of 2,405

Merck Sharp + Dohme Corp.

patents

7 out of 40

Memory Pharmaceuticals Corporation

patents

1 out of 2

Memory Pharmaceutical Corporation

patents

where one patent can have more than one assignee

Years Active: 2007-2023

Loading Chart...

Areas of Expertise:

Beta 3 Agonists

Chiral Dipeptidyl Peptidase-IV Inhibitors

Phosphodiesterase 4 Inhibitors

5-HT6 Receptor Affinity

N-Substituted Aniline

Diphenylamine Analogs

Intermediates

Compounds

Processes

Affinity

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11767292 - Process for making beta 3 agonists and intermediates (2023-09-26),

2. 11708371 - Process for making beta 3 agonists and intermediates (2023-07-25),

3. 11124478 - Process for making beta 3 agonists and intermediates (2021-09-21),

4. 10899771 - Process for making beta 3 agonists and intermediates (2021-01-26),

5. 10577316 - Process for making beta 3 agonists and intermediates (2020-03-03),

6. 10435410 - Process for making beta 3 agonists and intermediates (2019-10-08),

7. 10087189 - Process for making beta 3 agonists and intermediates (2018-10-02),

8. 9822121 - Process for making beta 3 agonists and intermediates (2017-11-21),

9. 9809536 - Process for making beta 3 agonists and intermediates (2017-11-07),

10. 9527855 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors (2016-12-27),

11. 9187488 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors (2015-11-17),

12. 7723348 - Phosphodiesterase 4 inhibitors (2010-05-25),

13. 7696229 - Compounds having 5-HT6 receptor affinity (2010-04-13),

14. 7696198 - Phosphodiesterase 4 inhibitors (2010-04-13),

15. 7585882 - Phosphodiesterase 4 inhibitors (2009-09-08),

Title: The Inventor Robert F Dunn: Pioneering Innovations in Towaco, NJ

Introduction: Robert F Dunn is a distinguished inventor based in Towaco, NJ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Robert F Dunn's latest patents include cutting-edge technologies in the fields of renewable energy, sustainable agriculture, and advanced robotics, showcasing his commitment to addressing pressing global challenges.

Career Highlights: With a career spanning over two decades, Robert F Dunn has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations: Throughout his career, Robert F Dunn has collaborated with leading research institutions, universities, and forward-thinking companies to bring his inventions to life, fostering a culture of innovation and collaboration in the industry.

Conclusion: Robert F Dunn's relentless pursuit of innovation and his passion for creating a positive impact on society have solidified his reputation as a trailblazing inventor in Towaco, NJ, inspiring the next generation of innovators to think boldly and push the limits of what technology can achieve.

Profile summary based on public USPTO records.